Profile of capillary-leak syndrome in patients received chimeric antigen receptor T cell therapy

Bone Marrow Transplant. 2022 Apr;57(4):661-663. doi: 10.1038/s41409-022-01562-4. Epub 2022 Jan 28.

Jingjing Feng^{1

2

3

4}, Mi Shao^{1

2

3

4}, Yongxian Hu^{5

6

7

8}, He Huang^{9

10

11

12}

¹ Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
² Liangzhu Laboratory, Zhejiang University Medical Center, 1369 West Wenyi Road, Hangzhou, China.
³ Institute of Hematology, Zhejiang University, Hangzhou, China.
⁴ Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
⁵ Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. 1313016@zju.edu.cn.
⁶ Liangzhu Laboratory, Zhejiang University Medical Center, 1369 West Wenyi Road, Hangzhou, China. 1313016@zju.edu.cn.
⁷ Institute of Hematology, Zhejiang University, Hangzhou, China. 1313016@zju.edu.cn.
⁸ Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China. 1313016@zju.edu.cn.
⁹ Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. huanghe@zju.edu.cn.
¹⁰ Liangzhu Laboratory, Zhejiang University Medical Center, 1369 West Wenyi Road, Hangzhou, China. huanghe@zju.edu.cn.
¹¹ Institute of Hematology, Zhejiang University, Hangzhou, China. huanghe@zju.edu.cn.
¹² Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China. huanghe@zju.edu.cn.

No abstract available

Publication types